What are the most common extrapyramidal side effects associated with antipsychotic medications?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 8, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Common Extrapyramidal Side Effects of Antipsychotic Medications

The most common extrapyramidal side effects (EPS) associated with antipsychotic medications include acute dystonia, drug-induced parkinsonism, akathisia, and tardive dyskinesia. 1, 2

Primary Types of Extrapyramidal Side Effects

1. Acute Dystonia

  • Characterized by involuntary motor tics or muscle spasms
  • Typically affects the face, extraocular muscles (oculogyric crisis), neck, back, and limb muscles
  • Usually occurs after the first few doses or after dose increases
  • Laryngeal dystonia is rare but potentially life-threatening (presents as choking sensation, difficulty breathing, or stridor)
  • Treatment: anticholinergic medications (benztropine) or antihistamines 1, 3

2. Drug-induced Parkinsonism

  • Clinically resembles idiopathic Parkinson's disease
  • Features include:
    • Bradykinesia (slowness of movement)
    • Tremor (especially at rest)
    • Rigidity
    • Postural instability
  • Generally appears within the first three months of treatment
  • Treatment options:
    • Reducing antipsychotic dose
    • Adding anticholinergic agent (benztropine 1-2 mg/day)
    • Adding amantadine
    • Switching to an atypical antipsychotic 1, 2, 3

3. Akathisia

  • Subjective feeling of restlessness and anxiety
  • Objective signs include motor restlessness and inability to sit still
  • Typically occurs within the first few days of treatment
  • Can be difficult to manage
  • Treatment approaches:
    • Reducing antipsychotic dose
    • Beta-blockers (especially propranolol)
    • Benzodiazepines
    • Anticholinergics (less effective for akathisia) 1, 2, 3

4. Tardive Dyskinesia

  • Characterized by rapid involuntary movements:
    • Facial movements (blinking, grimacing)
    • Chewing or tongue movements
    • Extremity or truncal movements
  • Occurs in approximately 5% of young patients per year
  • More common with older "typical" antipsychotics
  • Respiratory dyskinesia is often undiagnosed and can lead to recurrent aspiration pneumonia
  • Prevention and early detection are crucial 1, 2

Risk Factors for Developing EPS

  • Age (elderly and very young patients at higher risk)
  • Male sex
  • Previous history of tremors
  • Previous use of antipsychotics
  • Polypharmacy
  • Substance abuse
  • Higher doses of antipsychotics 2

Mechanism of EPS Development

EPS primarily occur due to blockade of dopamine D2 receptors in the nigrostriatal pathway, which is critical for normal motor function. This blockade creates an imbalance between dopaminergic and cholinergic activity in the basal ganglia, leading to various movement disorders 2, 4.

Prevention and Management

  • Use the lowest effective dose of antipsychotic medication
  • Consider atypical antipsychotics which generally have lower EPS risk
  • For high-risk patients, prophylactic anticholinergic therapy may be indicated, though routine prophylaxis is not recommended
  • Regular monitoring for abnormal movements, especially during prolonged treatment
  • Prompt recognition and treatment of EPS when they occur 2, 5

Important Considerations

  • EPS can significantly impact quality of life and medication adherence
  • Patients experiencing acute EPS are at greater risk for developing tardive dyskinesia later
  • Neuroleptic malignant syndrome, while rare, is a potentially life-threatening condition associated with antipsychotic use that includes rigidity as a key feature 1, 6, 7

Remember that while atypical antipsychotics generally have a lower risk of causing EPS compared to conventional antipsychotics, they can still cause these side effects, especially at higher doses or when used in combination with other medications 5, 6.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Antipsychotic Use in Patients with Parkinson's Disease

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Management of acute extrapyramidal effects induced by antipsychotic drugs.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 1997

Research

Novel antipsychotics, extrapyramidal side effects and tardive dyskinesia.

International clinical psychopharmacology, 1998

Research

Extrapyramidal side effects are unacceptable.

European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2001

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.